Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Clinithink and Newcastle Upon Tyne Hospitals NHS Foundation Trust Shortlisted for Prestigious HSJ Award


LONDON, Aug., 22, 2019 /PRNewswire/ -- Clinithink has been shortlisted for the Connecting Services and Information Award at this year's HSJ Awards for their joint submission with Newcastle Upon Tyne Hospitals NHS Foundation Trust.

The submission was based on a partnership that saw Clinithink's CLiX ENRICH solution successfully used by the Trust's clinical research staff to transform the way patients, who are potentially eligible to participate in clinical trials, are initially identified.

As the cost of patient recruitment continues to increase worldwide, the Trust's team had been seeking a more efficient patient recruitment model to support their clinical research function. Prior to the use of CLiX ENRICH, the research team at Newcastle Hospitals had spent three years manually reviewing over 2000 patients, identifying 30 potentially eligible candidates for one trial during that time. Using Clinithink's CLiX ENRICH solution the same team was able to process the records of 270,000 patients and identify people who were potentially highly eligible in less than 24 hours. This produced a shortlist of 100 patients in a fraction of the previous time. By utilising Clinithink's ENRICH platform, valuable time has been released to enable research staff to focus on patient interaction and, in turn, improve patient access to clinical research, with its associated benefits.

Chris Tackaberry, CEO of Clinithink, said of the news: "We are exceptionally proud to make the shortlist for the Connecting Services and Information Award at this year's HSJ Awards. Our work with Newcastle Hospitals has been truly exciting from the start, and to be recognised in this way for the impact our solution has made for the clinical team and their patients is terrific testimony to the hard work of all those involved on both sides of the collaboration. We await further news with great excitement!"

For the full story on Clinithink's work with Newcastle Upon Tyne Hospitals NHS Foundation Trust, please visit https://bit.ly/2KHukOy 

ABOUT CLINITHINK
Clinithink's CLiX software delivers exciting new insight for life science and healthcare by using AI/Clinical Natural Language Processing to extract the rich, unstructured data from a patient's medical record. For further information visit clinithink.com

ABOUT THE HSJ AWARDS
The most coveted accolade in UK healthcare, the HSJ awards is the largest annual benchmarking and recognition programme for the health sector.

SOURCE Clinithink


These press releases may also interest you

at 05:20
IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced that China National Medical Products Administration (NMPA) has approved the...

at 05:15
The "Flow Cytometry Markets. Forecasts by Technology, Product and Application. With Executive and Consultant Guides. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The technology is moving faster than the market. Find the...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 05:00
Medical equipment manufacturing company Aohua Endoscopy clinched the Endoscopy Product Innovation Award at the recently held Healthcare Asia Medtech Awards 2024 for its development of the Aohua 4K AQ-300 video endoscopy system, which offers an...

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: